Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.
Bashir B, Ho JH, Downie P, Hamilton P, Ferns G, Datta D, Cegla J, Wierzbicki AS, Dawson C, Jenkinson F, Delaney H, Mansfield M, Teoh Y, Miedzybrodzka Z, Haso H, Durrington PN, Soran H. Bashir B, et al. Among authors: teoh y. Metabolites. 2023 Apr 30;13(5):621. doi: 10.3390/metabo13050621. Metabolites. 2023. PMID: 37233662 Free PMC article. Review.
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
Bashir B, Kwok S, Wierzbicki AS, Jones A, Dawson C, Downie P, Jenkinson F, Delaney H, Mansfield M, Datta D, Teoh Y, Hamilton P, Forrester N, O'Sullivan D, Ferdousi M, Durrington PN, AbdelRazik A, Gallo A, Moulin P, Soran H. Bashir B, et al. Among authors: teoh y. Atherosclerosis. 2024 Apr;391:117476. doi: 10.1016/j.atherosclerosis.2024.117476. Epub 2024 Feb 10. Atherosclerosis. 2024. PMID: 38447437
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.
Bashir B, Downie P, Forrester N, Wierzbicki AS, Dawson C, Jones A, Jenkinson F, Mansfield M, Datta D, Delaney H, Teoh Y, Hamilton P, Ferdousi M, Kwok S, O'Sullivan D, Wang J, Hegele RA, Durrington PN, Soran H. Bashir B, et al. Among authors: teoh y. Arterioscler Thromb Vasc Biol. 2024 Nov;44(11):2334-2346. doi: 10.1161/ATVBAHA.124.320955. Epub 2024 Sep 5. Arterioscler Thromb Vasc Biol. 2024. PMID: 39234690 Free PMC article.
Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
Hopkins PN, Defesche J, Fouchier SW, Bruckert E, Luc G, Cariou B, Sjouke B, Leren TP, Harada-Shiba M, Mabuchi H, Rabès JP, Carrié A, van Heyningen C, Carreau V, Farnier M, Teoh YP, Bourbon M, Kawashiri MA, Nohara A, Soran H, Marais AD, Tada H, Abifadel M, Boileau C, Chanu B, Katsuda S, Kishimoto I, Lambert G, Makino H, Miyamoto Y, Pichelin M, Yagi K, Yamagishi M, Zair Y, Mellis S, Yancopoulos GD, Stahl N, Mendoza J, Du Y, Hamon S, Krempf M, Swergold GD. Hopkins PN, et al. Among authors: teoh yp. Circ Cardiovasc Genet. 2015 Dec;8(6):823-31. doi: 10.1161/CIRCGENETICS.115.001129. Epub 2015 Sep 15. Circ Cardiovasc Genet. 2015. PMID: 26374825 Free PMC article. Clinical Trial.
Understanding the long-term impact of the COVID-19 pandemic on non-muscle-invasive bladder cancer outcomes: 12-Month follow-up data from the international, prospective COVIDSurg Cancer study.
Alexander CE, Nathan A, Light A, Gao C, Chan V, Khadhouri S, Gallagher K, Byrnes KG, Walters M, Hughes T, Perry R, Okoth K, Magill L, Pinkney T, John JB, McGrath JS, Colquhoun A, Zhang Y, Blackmur J, Etchill E, Tang S, García Escudero D, Stewart G, Kasivisvanathan V; COVIDSurg Collaborative. Alexander CE, et al. BJUI Compass. 2024 Oct 15;5(11):1044-1051. doi: 10.1002/bco2.432. eCollection 2024 Nov. BJUI Compass. 2024. PMID: 39539562 Free PMC article.
118 results